Skip to main content
Premium Trial:

Request an Annual Quote

Six NIH Units Sign Up for Access to Affymetrix's GeneChip Technology

Premium

SANTA CLARA, Calif.--Affymetrix announced that six institutes of the US National Institutes of Health have agreed to a broad GeneChip technology access contract. They include: the National Cancer Institute; the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; the National Institute of Arthritis and Musculoskeletal and Skin Diseases; the National Institute of Child Health and Human Development; and, the National Institute of Health Clinical Center.

Under the agreement, NIH researchers will gain broad access to Affymetrix's standard and custom GeneChip arrays, instrumentation, and software to monitor gene expression in research activities. The agreement includes terms and conditions for use of the GeneChip technology, volume discounts, and minimum purchase commitments. The terms and conditions for use of the GeneChip technology by NIH researchers have been specially designed to allow for broad publication of scientific results and to facilitate collaborations with academic, governmental, and commercial scientific colleagues.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.